According to DataM Intelligence, the HIV Therapeutics Market Size grew to USD 37.61 billion in 2024 and is projected to reach USD 57.56 billion by 2033, advancing at a CAGR of 4.8% during the forecast ...
COPD experimental therapy 9MW1911 reduced moderate to severe exacerbations in a Phase 2a trial, showing a favorable safety ...
Trevi Therapeutics stock (TRVI) earns a Buy rating as Haduvio advances toward phase 3 for chronic cough in IPF. Read the full ...
Eight scientific posters demonstrate significant seizure reduction and improved outcomes with VNS Therapy in patients with Drug-Resistant Epilepsy ...
The meeting focused on Nexalin’s proposed clinical development plan and overall regulatory strategy for the Gen-2 SYNC ...
Muvon Therapeutics has linked its cell therapy to a 60% drop in stress incontinence episode frequency in a small phase 2 ...
MUVON Therapeutics AG, a clinical-stage biotechnology company, reports positive topline results from the Phase 2 clinical trial SUISSE-MPC2 (NCT05534269)evaluating its novel proprietary muscle ...
This peer-reviewed publication marks an important milestone following initial release of study information in August 2024 (see "Vaderis Announces Positive Clinical Proof-of-Concept Trial in HHT"). The ...
Western Kansas Therapy Associates (WKTA) is a behavioral health therapy office with two locations, in both downtown Hays and Phillipsburg. WKTA has a team of 17 licensed mental health therapists who ...
The global T-Cell lymphoma therapeutics market size was valued at US$ 2.3 Bn in 2024 and is projected to reach US$ 5.7 Bn by ...
Currentbody’s exceptional Cyber Week sale is still in full swing, making now the opportune time to indulge in firmer, more ...
Based on Stoke Therapeutics’ preliminary estimates, which scaled annual incidence to prevalence using country-specific live birth rates over the past 85 years and adjusted for Dravet-specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback